JP2002511926A - 磁性粒子を使用するアッセイ - Google Patents
磁性粒子を使用するアッセイInfo
- Publication number
- JP2002511926A JP2002511926A JP54500798A JP54500798A JP2002511926A JP 2002511926 A JP2002511926 A JP 2002511926A JP 54500798 A JP54500798 A JP 54500798A JP 54500798 A JP54500798 A JP 54500798A JP 2002511926 A JP2002511926 A JP 2002511926A
- Authority
- JP
- Japan
- Prior art keywords
- assay
- magnetic particles
- analyte
- magnetic field
- sensitive material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003556 assay Methods 0.000 title claims abstract description 65
- 239000006249 magnetic particle Substances 0.000 title claims abstract description 46
- 239000012491 analyte Substances 0.000 claims abstract description 53
- 239000000463 material Substances 0.000 claims abstract description 32
- 230000008859 change Effects 0.000 claims abstract description 30
- 230000005291 magnetic effect Effects 0.000 claims abstract description 28
- 230000000694 effects Effects 0.000 claims abstract description 5
- 229940088598 enzyme Drugs 0.000 claims description 32
- 108090000790 Enzymes Proteins 0.000 claims description 30
- 102000004190 Enzymes Human genes 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 17
- 229920000642 polymer Polymers 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 238000003018 immunoassay Methods 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 11
- 230000004044 response Effects 0.000 claims description 10
- 238000012544 monitoring process Methods 0.000 claims description 7
- 108010046334 Urease Proteins 0.000 claims description 6
- 239000000376 reactant Substances 0.000 claims description 5
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 4
- 230000003993 interaction Effects 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 108010015776 Glucose oxidase Proteins 0.000 claims description 2
- 239000004366 Glucose oxidase Substances 0.000 claims description 2
- 229940116332 glucose oxidase Drugs 0.000 claims description 2
- 235000019420 glucose oxidase Nutrition 0.000 claims description 2
- GAMPNQJDUFQVQO-UHFFFAOYSA-N acetic acid;phthalic acid Chemical compound CC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O GAMPNQJDUFQVQO-UHFFFAOYSA-N 0.000 claims 1
- 125000000129 anionic group Chemical group 0.000 claims 1
- 229920002301 cellulose acetate Polymers 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- -1 methyl vinyl ether maleic anhydride ester Chemical class 0.000 claims 1
- 238000005259 measurement Methods 0.000 abstract description 7
- 239000000427 antigen Substances 0.000 description 16
- 102000036639 antigens Human genes 0.000 description 16
- 108091007433 antigens Proteins 0.000 description 16
- 239000000306 component Substances 0.000 description 13
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- 229960002685 biotin Drugs 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 239000000700 radioactive tracer Substances 0.000 description 3
- 230000036962 time dependent Effects 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008364 bulk solution Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 108010065556 Drug Receptors Proteins 0.000 description 1
- 102000013138 Drug Receptors Human genes 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000007820 coagulation assay Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000002359 drug metabolite Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-M phthalate(1-) Chemical compound OC(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-M 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/72—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables
- G01N27/74—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables of fluids
- G01N27/745—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating magnetic variables of fluids for detecting magnetic beads used in biochemical assays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Electrochemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Soft Magnetic Materials (AREA)
- Hard Magnetic Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Paints Or Removers (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 被分析物の存在に関する、あるいは生物学的又は医学的パラメーターを測定 するためのアッセイにおいて、 磁性粒子を充填されたpH感受性材料にアッセイ成分を添加して、アッセイ 成分に被分折物又は測定されるパラメーターのファンクションであるpH変化を 生じさせ; 磁性粒子を振動磁界におき;かつ 磁性粒子に対する磁界の効果を測定することを特徴とする、被分析物の存在 に関する、あるいは生物学的又は医学的パラメーターを測定するためのアッセイ 。 2. アッセイされる標本と反応種との相互作用からアッセイ成分が生じる、請求 項1に記載のアッセイ。 3. 被分析物の存在に関するアッセイにおいて、 被分析物の存在に関してアッセイされる標本を反応種に接触させて、被分析 物を反応種と相互に作用させてpH変化を生じさせ; 磁性粒子で充填されたpH感受性材料と直接又は間接に反応させ; 磁界を磁性粒子に適用し; 磁界に対する前記の磁性粒子の応答をモニターし;かつ 磁性粒子の応答を分析することにより前記の標本中の被分析物の量を測定す る ことを特徴とする、被分析物の存在に関するアッセイ。 4. 生物学的又は医学的パラメーターを測定するためのアッセイにおいて、 生物学的又は医学的パラメーターに関してアッセイされる標本を反応種に接 触させて、標本を反応種と相互に作用させてpH変化を生じさせ; 磁性粒子で充填されたpH感受性材料と直接又は間接に反応させ; 磁界を磁性粒子に適用し; 磁界に対する前記の磁性粒子の応答をモニターし;かつ 磁性粒子の応答を分析することによりパラメーターを測定することを特徴と する、生物学的又は医学的パラメーターを測定するためのアッセイ。 5. 反応種がウレアーゼ又はグルコースオキシダーゼである、請求項2から5ま でのいずれか1項に記載のアッセイ。 6. アッセイ成分がヒドロキシル基である、請求項1又は2に記載のアッセイ。 7. pH感受性材料が腸溶ポリマー、有利には酢酸水素フタル酸セルロース、メ チルビニルエーテルマレイン酸無水物エステル、メタクリル酸のアニオン性 ポリマー又はメタクリル酸のエステルである、請求項1から6までのいずれか1 項に記載のアッセイ。 8. アッセイがイムノアッセイ、有利に酵素イムノアッセイである、請求項1か ら7のいずれか1項に記載のアッセイ。 9. 結合対反応により生じるpHが標本中の被分析物の存在又は標本の生物学的 又は医学的パラメーターのファンクションであり、かつpH感受性材料からの磁 性粒子の遊離を検出することを特徴とする、結合対アッセイ。 10.pH感受性材料中に捕捉された磁性粒子を含む反応チャンバ、磁界を発生さ せるための装置及び検出装置を有する、請求項1から9までのいずれか1項に記 載のアッセイを実施するためのキット。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97302671.9 | 1997-04-18 | ||
EP97302671A EP0872736A1 (en) | 1997-04-18 | 1997-04-18 | Assay utilizing magnetic particles |
PCT/EP1998/002308 WO1998048282A1 (en) | 1997-04-18 | 1998-04-20 | Assay utilizing magnetic particles |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002511926A true JP2002511926A (ja) | 2002-04-16 |
JP3693680B2 JP3693680B2 (ja) | 2005-09-07 |
Family
ID=8229303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54500798A Expired - Fee Related JP3693680B2 (ja) | 1997-04-18 | 1998-04-20 | 磁性粒子を使用するアッセイ |
Country Status (9)
Country | Link |
---|---|
US (1) | US6235491B1 (ja) |
EP (2) | EP0872736A1 (ja) |
JP (1) | JP3693680B2 (ja) |
AT (1) | ATE224544T1 (ja) |
DE (1) | DE69808071T2 (ja) |
DK (1) | DK0975974T3 (ja) |
ES (1) | ES2184260T3 (ja) |
PT (1) | PT975974E (ja) |
WO (1) | WO1998048282A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008504560A (ja) * | 2004-06-28 | 2008-02-14 | ベクトン・ディキンソン・アンド・カンパニー | 溶解性フィルムおよびそれを含む方法 |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0872736A1 (en) * | 1997-04-18 | 1998-10-21 | Byk Gulden Italia S.p.A. | Assay utilizing magnetic particles |
US20030119203A1 (en) | 2001-12-24 | 2003-06-26 | Kimberly-Clark Worldwide, Inc. | Lateral flow assay devices and methods for conducting assays |
US8367013B2 (en) * | 2001-12-24 | 2013-02-05 | Kimberly-Clark Worldwide, Inc. | Reading device, method, and system for conducting lateral flow assays |
US7285424B2 (en) | 2002-08-27 | 2007-10-23 | Kimberly-Clark Worldwide, Inc. | Membrane-based assay devices |
US7314763B2 (en) * | 2002-08-27 | 2008-01-01 | Kimberly-Clark Worldwide, Inc. | Fluidics-based assay devices |
US7781172B2 (en) | 2003-11-21 | 2010-08-24 | Kimberly-Clark Worldwide, Inc. | Method for extending the dynamic detection range of assay devices |
US20040106190A1 (en) * | 2002-12-03 | 2004-06-03 | Kimberly-Clark Worldwide, Inc. | Flow-through assay devices |
US7247500B2 (en) * | 2002-12-19 | 2007-07-24 | Kimberly-Clark Worldwide, Inc. | Reduction of the hook effect in membrane-based assay devices |
US7851209B2 (en) * | 2003-04-03 | 2010-12-14 | Kimberly-Clark Worldwide, Inc. | Reduction of the hook effect in assay devices |
US20040197819A1 (en) * | 2003-04-03 | 2004-10-07 | Kimberly-Clark Worldwide, Inc. | Assay devices that utilize hollow particles |
US7943395B2 (en) | 2003-11-21 | 2011-05-17 | Kimberly-Clark Worldwide, Inc. | Extension of the dynamic detection range of assay devices |
US7713748B2 (en) | 2003-11-21 | 2010-05-11 | Kimberly-Clark Worldwide, Inc. | Method of reducing the sensitivity of assay devices |
US20050112703A1 (en) | 2003-11-21 | 2005-05-26 | Kimberly-Clark Worldwide, Inc. | Membrane-based lateral flow assay devices that utilize phosphorescent detection |
US20050136550A1 (en) * | 2003-12-19 | 2005-06-23 | Kimberly-Clark Worldwide, Inc. | Flow control of electrochemical-based assay devices |
US7943089B2 (en) | 2003-12-19 | 2011-05-17 | Kimberly-Clark Worldwide, Inc. | Laminated assay devices |
GB0413752D0 (en) * | 2004-06-19 | 2004-07-21 | Hall Effect Technologies Ltd | Method of determining the presence and/or concentration of substances of interest in fluids |
WO2006056001A1 (de) * | 2004-11-25 | 2006-06-01 | Thomas Schlederer | Vorrichtung zur qualitativen und quantitativen bestimmung von analyten |
CN106771199B (zh) * | 2016-11-18 | 2018-06-22 | 湖北师范大学 | 一种用于非诊断目的的检测肿瘤标志物的比色免疫分析方法 |
GB2566995B (en) * | 2017-09-29 | 2023-01-18 | Cotton Mouton Diagnostics Ltd | A method of detection |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5110727A (en) * | 1987-04-03 | 1992-05-05 | Cardiovascular Diagnostics, Inc. | Method for performing coagulation assays accurately, rapidly and simply, using dry chemical reagents and paramagnetic particles |
CA2156174A1 (en) | 1993-02-17 | 1994-09-01 | Bruce Oberhardt | Dry chemistry cascade immunoassay and affinity assay |
GB2284890A (en) * | 1993-12-17 | 1995-06-21 | Cambridge Life Sciences | Analyte sensor based on polymer porosity changes |
ATE156270T1 (de) * | 1993-05-29 | 1997-08-15 | Cambridge Life Sciences | Sensoren beruhend auf polymerumwandlung |
WO1995006868A1 (en) | 1993-08-31 | 1995-03-09 | Boehringer Mannheim Corporation | Reagent and method of its use |
EP0872736A1 (en) * | 1997-04-18 | 1998-10-21 | Byk Gulden Italia S.p.A. | Assay utilizing magnetic particles |
-
1997
- 1997-04-18 EP EP97302671A patent/EP0872736A1/en not_active Withdrawn
-
1998
- 1998-04-20 EP EP98921469A patent/EP0975974B1/en not_active Expired - Lifetime
- 1998-04-20 DE DE69808071T patent/DE69808071T2/de not_active Expired - Lifetime
- 1998-04-20 ES ES98921469T patent/ES2184260T3/es not_active Expired - Lifetime
- 1998-04-20 DK DK98921469T patent/DK0975974T3/da active
- 1998-04-20 PT PT98921469T patent/PT975974E/pt unknown
- 1998-04-20 AT AT98921469T patent/ATE224544T1/de not_active IP Right Cessation
- 1998-04-20 WO PCT/EP1998/002308 patent/WO1998048282A1/en active IP Right Grant
- 1998-04-20 US US09/403,012 patent/US6235491B1/en not_active Expired - Fee Related
- 1998-04-20 JP JP54500798A patent/JP3693680B2/ja not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008504560A (ja) * | 2004-06-28 | 2008-02-14 | ベクトン・ディキンソン・アンド・カンパニー | 溶解性フィルムおよびそれを含む方法 |
JP2012108149A (ja) * | 2004-06-28 | 2012-06-07 | Becton Dickinson & Co | 溶解性フィルムおよびそれを含む方法 |
US9267167B2 (en) | 2004-06-28 | 2016-02-23 | Becton, Dickinson And Company | Dissolvable films and methods including the same |
US9410185B2 (en) | 2004-06-28 | 2016-08-09 | Becton, Dickinson And Company | Dissolvable films and methods including the same |
Also Published As
Publication number | Publication date |
---|---|
US6235491B1 (en) | 2001-05-22 |
ATE224544T1 (de) | 2002-10-15 |
EP0872736A1 (en) | 1998-10-21 |
WO1998048282A1 (en) | 1998-10-29 |
EP0975974A1 (en) | 2000-02-02 |
ES2184260T3 (es) | 2003-04-01 |
JP3693680B2 (ja) | 2005-09-07 |
DK0975974T3 (da) | 2003-01-20 |
DE69808071T2 (de) | 2003-05-28 |
DE69808071D1 (de) | 2002-10-24 |
EP0975974B1 (en) | 2002-09-18 |
PT975974E (pt) | 2003-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3693680B2 (ja) | 磁性粒子を使用するアッセイ | |
JP3726082B2 (ja) | 特異結合分析方法およびそれに用いる特異結合分析装置 | |
Wang et al. | A paper-based device with an adjustable time controller for the rapid determination of tumor biomarkers | |
JPH08501627A (ja) | 自己確認効力検定装置 | |
JP4328203B2 (ja) | 多数−スポット検出ゾーンでの多数−分析物アッセイデバイス | |
US8758686B2 (en) | Optical chemical sensing device with pyroelectric or piezoelectric transducer | |
US9575077B2 (en) | TSH antibodies for point-of-care immunoassay formats | |
JP3908272B2 (ja) | リガンドの検出のための固相アッセイ | |
JP5938471B2 (ja) | Tsh免疫アッセイ及び内在性夾雑物の存在下におけるtsh免疫アッセイを限定的な洗浄フォーマットで実施するための方法 | |
JPWO2003029822A1 (ja) | 特異結合分析装置および特異結合分析方法 | |
KR20190058357A (ko) | 고농도 검체 내 표적물질 정량화가 가능한 광범위 체외 진단 키트 | |
JP4113956B2 (ja) | 水晶振動子を用いた微量物質の測定方法 | |
JP4972295B2 (ja) | 免疫分析方法及びバイオチップ | |
JP2003161733A (ja) | 特異結合分析方法および特異結合分析デバイス | |
JP2000155122A (ja) | 微小酸素電極を利用した特異的結合対測定方法 | |
JP3598334B2 (ja) | 水晶振動子を利用した測定試薬及び測定方法 | |
JP2572812B2 (ja) | ペースト状試料中の分析物を測定するためのテストキット | |
JP3598333B2 (ja) | 水晶振動子を用いた測定試薬及び測定方法 | |
JP4470354B2 (ja) | 1〜100ulの試料のためのインビボ検査装置 | |
JP3481894B2 (ja) | 免疫学的クロマト方式を利用した測定方法 | |
CN114814243B (zh) | 应用于蛋白质抗原的定量检测试剂盒及方法 | |
JP2009085703A (ja) | 高感度免疫測定方法 | |
JPH08114595A (ja) | 特異的結合測定法 | |
JP3543655B2 (ja) | 試料の確認方法及びキット | |
JPH06103307B2 (ja) | 免疫分析方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040602 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040907 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20041203 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050124 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050307 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050531 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050622 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090701 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100701 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110701 Year of fee payment: 6 |
|
LAPS | Cancellation because of no payment of annual fees |